1. Home
  2. OBIO vs THRY Comparison

OBIO vs THRY Comparison

Compare OBIO & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.21

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$5.26

Market Cap

257.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBIO
THRY
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
257.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OBIO
THRY
Price
$4.21
$5.26
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$14.25
$14.00
AVG Volume (30 Days)
217.8K
1.0M
Earning Date
11-10-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
$2,818,000.00
$779,992,000.00
Revenue This Year
$35.75
N/A
Revenue Next Year
$3.07
N/A
P/E Ratio
N/A
$12.85
Revenue Growth
6.46
N/A
52 Week Low
$2.20
$5.12
52 Week High
$6.16
$20.92

Technical Indicators

Market Signals
Indicator
OBIO
THRY
Relative Strength Index (RSI) 45.38 33.53
Support Level $4.06 $5.24
Resistance Level $4.53 $5.53
Average True Range (ATR) 0.30 0.27
MACD -0.03 -0.03
Stochastic Oscillator 24.88 10.34

Price Performance

Historical Comparison
OBIO
THRY

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

Share on Social Networks: